- Home
- INM vs SILO Comparison
INM vs SILO Comparison
Compare INM & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- SILO
- Stock Information
- Founded
- INM 1981
- SILO 2010
- Country
- INM Canada
- SILO United States
- Employees
- INM N/A
- SILO N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- INM Health Care
- SILO Consumer Discretionary
- Exchange
- INM Nasdaq
- SILO Nasdaq
- Market Cap
- INM 3.2M
- SILO 4.3M
- IPO Year
- INM N/A
- SILO N/A
- Fundamental
- Price
- INM $3.09
- SILO $0.62
- Analyst Decision
- INM
- SILO
- Analyst Count
- INM 0
- SILO 0
- Target Price
- INM N/A
- SILO N/A
- AVG Volume (30 Days)
- INM 9.5M
- SILO 2.2M
- Earning Date
- INM 05-12-2025
- SILO 08-12-2025
- Dividend Yield
- INM N/A
- SILO N/A
- EPS Growth
- INM N/A
- SILO N/A
- EPS
- INM N/A
- SILO N/A
- Revenue
- INM $4,920,990.00
- SILO $72,102.00
- Revenue This Year
- INM N/A
- SILO $1.86
- Revenue Next Year
- INM N/A
- SILO N/A
- P/E Ratio
- INM N/A
- SILO N/A
- Revenue Growth
- INM N/A
- SILO N/A
- 52 Week Low
- INM $1.72
- SILO $0.41
- 52 Week High
- INM $15.70
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- INM 51.86
- SILO 47.67
- Support Level
- INM $3.32
- SILO $0.60
- Resistance Level
- INM $5.50
- SILO $0.66
- Average True Range (ATR)
- INM 0.37
- SILO 0.04
- MACD
- INM 0.06
- SILO 0.01
- Stochastic Oscillator
- INM 24.69
- SILO 46.06
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.